Clot Care Images
DVT Awareness | Join Our Email List | Tuesday, September 07, 2010

Postings on Outpatient Treatment

For Patients and Caregivers

Posting Date Posted
INR Patient Self Testing Video Demo October, 2009
Is it Safe to Send Stable Anticoagulation Clinic Patients Back to Usual Medical Care? No! April, 2008
Should 3rd Generation Birth Control Pills be Banned? - Petition to Ban 3rd Generation OCs due to Increased Clotting Risk March, 2007
Should 3rd Generation Birth Control Pills be Banned? - Opposition to a Petition to Ban 3rd Generation OCs March, 2007
Telephone Versus In-Office Anticoagulation Management January, 2007
The Pulmonary Embolism Support Group - Support for Individuals with DVT or PE January, 2007
Cedric Bills' DVT Story March, 2006
Largest study yet confirms benefits of clinical pharmacy managed anticoagulation service June, 2005
FDA Rejects Ximelagatran (brand name Exanta) October, 2004
Patient Self Testing May, 2004
Understanding Atrial Fibrillation

Frequently Asked Questions Date Posted
Lab or POC INR Results - Which are more reliable? February, 2009
Where can I find a support group or meet others who have had a DVT, PE, or clotting disorder? January, 2007
I am taking warfarin (brand name Coumadin) for a blood clot in my leg (DVT). Will the pain in my leg ever go away? February, 2006
What are graduated compression stockings, where do I get them, and how do I put them on? February, 2006
Where can I find an anticoagulation expert near my home or office? October, 2005

For Health Care Providers

Posting Date Posted
New study and accompanying editorial suggest that warfarin may be indicated in fewer patients, but (as usual) issues remain January, 2010
INR Patient Self Testing Video Demo October, 2009
Is it Safe to Send Stable Anticoagulation Clinic Patients Back to Usual Medical Care? No! April, 2008
Warfarin more effective and at least as safe as low dose aspirin in elderly patients with atrial fibrillation September, 2007
Should we shorten treatment of DVT and PE to 3 months? Not yet. April, 2007
Should 3rd Generation Birth Control Pills be Banned? - Petition to Ban 3rd Generation OCs due to Increased Clotting Risk March, 2007
Should 3rd Generation Birth Control Pills be Banned? - Opposition to a Petition to Ban 3rd Generation OCs March, 2007
Should we be treating fewer patients with warfarin (Coumadin)? March, 2007
Should we be treating more patients with warfarin (Coumadin)? March, 2007
Telephone Versus In-Office Anticoagulation Management January, 2007
The Pulmonary Embolism Support Group - Support for Individuals with DVT or PE January, 2007
d-Dimer Found Useful in Decision to Continue Anticoagulation Following First Idiopathic VTE December, 2006
Major Bleeding Events Lead to Under Use of Anticoagulation in Atrial Fibrillation, but Ischemic Strokes do not Alter Prescribing Practices February, 2006
Daily Low-dose Vitamin K Supplementation Stabilizes INRs February, 2006
Poor Early Anticoagulation Control Associated with Near 3-fold Increase in DVT Recurrence and Post-thrombotic Syndrome January, 2006
Risk and Benefits of Aspirin in Primary Prevention in Both Men and Women Better Defined January, 2006
New Data Fuels Continued Controversy About Anti-Phospholipid Antibody (APA) and Lupus Anticoagulant Management (LAC) November, 2005
Appropriate Use of Anticoagulation in Atrial Fibrillation Patients Dramatically Increased with Availability of Anticoagulation Management Service October, 2005
Advanced age affects major bleeding and major thromboembolic rates in patients with high target INRs October, 2005
Anticoagulation Training Programs September, 2005
What Happened to Ximelagatran? March, 2005
New Study Supports INR of 2 to 3 for Elderly Patients with A. Fib. November, 2004
FDA Rejects Ximelagatran (brand name Exanta) October, 2004
Study and Editorial Address Three-Fold Greater Recurrence of DVT in Men September, 2004
New Supplement Devoted to Factor Xa Inhibitors (fondaparinux) August, 2004
New Anticoagulants to Displace or Reshape Anticoagulation Clinics April, 2004
Fondaparinux, LMWH, or UFH for PE? February, 2004
Low Molecular Weight Heparin Preferred for Pulmonary Embolism? February, 2004
Ximelagatran (brand name Exanta) is Leading the Coming Revolution in Stroke Prevention in Atrial Fibrillation -- Two New Studies January, 2004

Frequently Asked Questions Date Posted
Where can I find an anticoagulation expert near my home or office? October, 2005
Copyright 2000-2010 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
Send comments to webmaster@clotcare.org.
ClotCare is a charitable 501(c)(3) non-profit organization. Click here to donate.
ClotCare Online Resource covers topics such as Coumadin, warfarin, blood clot, stroke, heart attack, INR, PT, low molecular weight haparin, heparin, dvt, anticoagulation, antithrombotic therapy, A. fib, atrial fibrillation, heart valve, heart valve replacement, vitamin k, AstraZeneca, Aventis, CE credit, and more.